Not yet recruitingPhase 3
Impact of Intraoperative Arteriography with Indocyanine Green in Preserving the Parathyroid Glands During Total Thyroidectomy With or Without Central Cervical Lymph Node Dissection. A Multicenter Prospective Randomized Trial.
Key facts
- Who runs it
- Bellvitge University Hospital
- Where
- Spain3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 394 people, planned
- Started
- 11 Dec 2023
- Expected to end
- 11 Dec 2026
- Type of study
- Interventional
- Record updated
- 29 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients ≥18 years of age with a surgical indication for total thyroidectomy with or without central cervical lymph node dissection due to thyroid disease
- The patient or legal guardian can understand the study and agrees to participate by signing the written informed consent
Who cannot take part
- Previous surgical intervention on the thyroid or parathyroid gland
- Evidence of associated hyperparathyroidism requiring a parathyroidectomy in the same surgical procedure
- Patients with known contraindications to ICG
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To study whether using green indocyanine (ICG) arteriography before thyroidectomy to identify the parathyroid glands (PG) vascular pattern decreases the rate of permanent hypoparathyroidism.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Record updated
- 29 August 2025